|
12-chemokine gene expression score in breast cancer patients treated with neoadjuvant chemotherapy. |
|
|
Consulting or Advisory Role - AstraZeneca; Celgene; Lilly; Novartis; Pfizer; Puma Biotechnology |
Research Funding - Amgen (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Lilly |
|
|
Travel, Accommodations, Expenses - Medtronic |
|
|
No Relationships to Disclose |
|
|
Honoraria - Cianna Medical |
Consulting or Advisory Role - Cianna Medical; Merit Medical Systems |
Speakers' Bureau - Cardinal Health; Myriad Genetics |
Research Funding - Agendia; Cianna Medical; Paradigm; PreludeDx |
Travel, Accommodations, Expenses - Cianna Medical; Myriad Genetics |
|
|
Stock and Other Ownership Interests - Cerebrotech Medical Systems (I); Integra LifeSciences (I); MedNeon; Targeted Medical Education, Inc. |
|
Consulting or Advisory Role - Becton Dickinson; Cianna Medical; ImpediMed; Lumicell; Medtronic; Prelude Therapeutics |
Research Funding - Agendia; Intact Medical; InVitae; Prelude Therapeutics |
Travel, Accommodations, Expenses - Targeted Medical Education, Inc. |
|
|
|
|
|
|
Patents, Royalties, Other Intellectual Property - NXT Biologics |
|
|
|
|
|
No Relationships to Disclose |